CMB TECH NV (CMBT) Fundamental Analysis & Valuation

NYSE:CMBT • BE0003816338

Current stock price

12.85 USD
-0.02 (-0.16%)
At close:
12.78 USD
-0.07 (-0.54%)
After Hours:

This CMBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CMBT Profitability Analysis

1.1 Basic Checks

  • In the past year CMBT has reported negative net income.
  • In the past year CMBT had a positive cash flow from operations.
  • Of the past 5 years CMBT 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: CMBT reported negative operating cash flow in multiple years.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

  • The Return On Assets of CMBT (3.67%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 12.04%, CMBT is in the better half of the industry, outperforming 66.51% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.25%, CMBT is in line with its industry, outperforming 40.19% of the companies in the same industry.
Industry RankSector Rank
ROA 3.67%
ROE 12.04%
ROIC 4.25%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • CMBT's Profit Margin of 17.42% is fine compared to the rest of the industry. CMBT outperforms 71.77% of its industry peers.
  • CMBT's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 23.08%, CMBT is in the better half of the industry, outperforming 64.59% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CMBT has declined.
  • The Gross Margin of CMBT (52.84%) is better than 60.29% of its industry peers.
  • In the last couple of years the Gross Margin of CMBT has declined.
Industry RankSector Rank
OM 23.08%
PM (TTM) 17.42%
GM 52.84%
OM growth 3Y-1.6%
OM growth 5Y-12.14%
PM growth 3Y-25.83%
PM growth 5Y-24.32%
GM growth 3Y-1.12%
GM growth 5Y-6.04%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1

2. CMBT Health Analysis

2.1 Basic Checks

  • CMBT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for CMBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.86, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.86, CMBT is in line with its industry, outperforming 41.15% of the companies in the same industry.
  • A Debt/Equity ratio of 1.96 is on the high side and indicates that CMBT has dependencies on debt financing.
  • The Debt to Equity ratio of CMBT (1.96) is worse than 77.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACC0.6
WACC7.15%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • CMBT has a Current Ratio of 0.62. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CMBT has a worse Current ratio (0.62) than 77.99% of its industry peers.
  • CMBT has a Quick Ratio of 0.62. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.51, CMBT is doing worse than 80.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.51
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. CMBT Growth Analysis

3.1 Past

  • The earnings per share for CMBT have decreased strongly by -106.08% in the last year.
  • Measured over the past years, CMBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.73% on average per year.
  • CMBT shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.96%.
  • Measured over the past years, CMBT shows a small growth in Revenue. The Revenue has been growing by 6.60% on average per year.
EPS 1Y (TTM)-106.08%
EPS 3Y-11.23%
EPS 5Y-20.73%
EPS Q2Q%27.27%
Revenue 1Y (TTM)67.96%
Revenue growth 3Y24.92%
Revenue growth 5Y6.6%
Sales Q2Q%160.64%

3.2 Future

  • The Earnings Per Share is expected to grow by 78.02% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CMBT will show a quite strong growth in Revenue. The Revenue will grow by 13.07% on average per year.
EPS Next Y658.17%
EPS Next 2Y140.28%
EPS Next 3Y78.02%
EPS Next 5YN/A
Revenue Next Year39.77%
Revenue Next 2Y18.01%
Revenue Next 3Y13.07%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

4

4. CMBT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CMBT. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 10.23, the valuation of CMBT can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, CMBT is valued cheaper than 80.86% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, CMBT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.23
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMBT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.38
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CMBT's earnings are expected to grow with 78.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y140.28%
EPS Next 3Y78.02%

4

5. CMBT Dividend Analysis

5.1 Amount

  • CMBT has a Yearly Dividend Yield of 1.12%. Purely for dividend investing, there may be better candidates out there.
  • CMBT's Dividend Yield is comparable with the industry average which is at 3.26.
  • Compared to the average S&P500 Dividend Yield of 1.81, CMBT is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.12%

5.2 History

  • The dividend of CMBT is nicely growing with an annual growth rate of 116.35%!
  • CMBT has been paying a dividend for over 5 years, so it has already some track record.
  • CMBT has decreased its dividend recently.
Dividend Growth(5Y)116.35%
Div Incr Years1
Div Non Decr Years1
CMBT Yearly Dividends per shareCMBT Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • 7.67% of the earnings are spent on dividend by CMBT. This is a low number and sustainable payout ratio.
  • CMBT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP7.67%
EPS Next 2Y140.28%
EPS Next 3Y78.02%
CMBT Yearly Income VS Free CF VS DividendCMBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B
CMBT Dividend Payout.CMBT Dividend Payout, showing the Payout Ratio.CMBT Dividend Payout.PayoutRetained Earnings

CMBT Fundamentals: All Metrics, Ratios and Statistics

CMB TECH NV

NYSE:CMBT (4/24/2026, 8:04:00 PM)

After market: 12.78 -0.07 (-0.54%)

12.85

-0.02 (-0.16%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-26
Earnings (Next)05-19
Inst Owners13.23%
Inst Owner Change0.33%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.06B
Revenue(TTM)2.36B
Net Income(TTM)306.64M
Analysts81.54
Price Target15.5 (20.62%)
Short Float %1.11%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield 1.12%
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP7.67%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-14
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-173.2%
Min EPS beat(2)-198.04%
Max EPS beat(2)-148.37%
EPS beat(4)0
Avg EPS beat(4)-136.26%
Min EPS beat(4)-198.04%
Max EPS beat(4)-49.61%
EPS beat(8)3
Avg EPS beat(8)39.77%
EPS beat(12)7
Avg EPS beat(12)35.97%
EPS beat(16)10
Avg EPS beat(16)32.67%
Revenue beat(2)2
Avg Revenue beat(2)34.8%
Min Revenue beat(2)22.8%
Max Revenue beat(2)46.8%
Revenue beat(4)3
Avg Revenue beat(4)17.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)46.8%
Revenue beat(8)6
Avg Revenue beat(8)22.7%
Revenue beat(12)10
Avg Revenue beat(12)33.52%
Revenue beat(16)14
Avg Revenue beat(16)39.69%
PT rev (1m)8.25%
PT rev (3m)17.82%
EPS NQ rev (1m)-10.2%
EPS NQ rev (3m)7.48%
EPS NY rev (1m)1.33%
EPS NY rev (3m)-4.34%
Revenue NQ rev (1m)-2.1%
Revenue NQ rev (3m)1.08%
Revenue NY rev (1m)7.18%
Revenue NY rev (3m)5.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.23
P/S 2.31
P/FCF N/A
P/OCF 12.46
P/B 1.59
P/tB 1.72
EV/EBITDA 13.38
EPS(TTM)-0.22
EYN/A
EPS(NY)1.26
Fwd EY9.77%
FCF(TTM)-2.94
FCFYN/A
OCF(TTM)1.03
OCFY8.03%
SpS5.57
BVpS8.06
TBVpS7.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 3.67%
ROE 12.04%
ROCE 5.39%
ROIC 4.25%
ROICexc 4.25%
ROICexgc 4.37%
OM 23.08%
PM (TTM) 17.42%
GM 52.84%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.6%
OM growth 5Y-12.14%
PM growth 3Y-25.83%
PM growth 5Y-24.32%
GM growth 3Y-1.12%
GM growth 5Y-6.04%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA 6.9
Cap/Depr 395.78%
Cap/Sales 71.33%
Interest Coverage 1.53
Cash Conversion 45.05%
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.51
Altman-Z 0.86
F-Score3
WACC7.15%
ROIC/WACC0.6
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.08%
EPS 3Y-11.23%
EPS 5Y-20.73%
EPS Q2Q%27.27%
EPS Next Y658.17%
EPS Next 2Y140.28%
EPS Next 3Y78.02%
EPS Next 5YN/A
Revenue 1Y (TTM)67.96%
Revenue growth 3Y24.92%
Revenue growth 5Y6.6%
Sales Q2Q%160.64%
Revenue Next Year39.77%
Revenue Next 2Y18.01%
Revenue Next 3Y13.07%
Revenue Next 5YN/A
EBIT growth 1Y-35.16%
EBIT growth 3Y22.92%
EBIT growth 5Y-6.34%
EBIT Next Year146.1%
EBIT Next 3Y30%
EBIT Next 5YN/A
FCF growth 1Y-499.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.43%
OCF growth 3YN/A
OCF growth 5YN/A

CMB TECH NV / CMBT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CMB TECH NV (CMBT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CMBT.


Can you provide the valuation status for CMB TECH NV?

ChartMill assigns a valuation rating of 4 / 10 to CMB TECH NV (CMBT). This can be considered as Fairly Valued.


Can you provide the profitability details for CMB TECH NV?

CMB TECH NV (CMBT) has a profitability rating of 4 / 10.


How financially healthy is CMB TECH NV?

The financial health rating of CMB TECH NV (CMBT) is 1 / 10.


What is the earnings growth outlook for CMB TECH NV?

The Earnings per Share (EPS) of CMB TECH NV (CMBT) is expected to grow by 658.17% in the next year.